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ABSTRACT 
Transgenic mice produced in this investigation contained the proximal promoter 
elements. the genomic coding sequence and the 3' flanking region of bovine fJ-casein 
and the 5' regulatory elements of bovine a-lactalbumin. Specifically, the gene 
construct included the TATAA box, CAAT box and polyadenylation signal of 
bovine fJ-casein in addition to the 5' regulatory elements of the bovine a-lactalbumin 
gene. Four lines of transgenic mice were generated; they expressed bovine {3-casein 
in their milk at concentrations of up to 10 mg mL-I. The milk from the transgenic 
mice tended to be very viscous and a proportion of these mice stopped lactating 
before the normal onset of involution. The time at which the abrupt involution 
occurred was directly correlated to the amount of fJ-casein produced. Mice secreting 
approximately 10 mg mL-I of fJ-casein in their milk stopped lactating approxi­
mately 1-3 days after parturition while mice expressing 1-3 mg mL-I stopped 
lactating around days 10-18. The high expressing mice appeared to lactate 
normally on day 1 of lactation, but on day 3 the mammary gland morphology 
revealed alveoli and ducts which were very distended and contained milk compo­
nents. However, the viscous milk solution could not be removedfrom the gland at 
this stage of lactation. There were also a number of alveoli that appeared to have 
gone through the process of involution by day 3 of lactation. 
INTRODUCTION 
Bovine a-lactalbumin (a-la) regulatory regions have been shown to drive the 
production of foreign proteins in the milk of transgenic mice in our laboratory as 
*To whom correspondence should be addressed. 
well as by others (Vilotte et al., 1989; Bleck & Bremel, 1991; Stinnakre et al., 
1991; Soulier et aI., 1992). It appears from these studies that most of the cis-acting 
regulatory elements needed for maximal production of bovine a-la in the milk of 
transgenic mice are present in the 5' flanking region of the gene. To confirm that 
the bovine a-lactalbumin 5' flanking region was capable of driving high-level 
expression of a foreign protein in the milk of transgenic animals and to generate a 
gene construct that could be used to modify the characteristics and composition 
of bovine milk, transgenic mice were produced containing a bovine f)-casein gene 
construct that was controlled by the bovine a-lactalbumin 5' flanking region. 
Bovine f)-casein was chosen for analysis due to its potential usefulness in the 
modification of physical properties of the milk. The addition of f)-casein to cows' 
milk can increase the speed of curd formation and the cheese curd firmness 
(Richardson et al., 1992). Thus, an increase in the production of f)-casein will also 
increase the cheese yield of the milk. It has been hypothesized that the production 
of a modified f)-casein in cows' milk can change the functional characteristics of 
the milk. The addition of a glycosylation site at amino acids 7 or 27 is postulated 
to increase the emulsifying, foaming and gelling characteristics of f)-casein in the 
milk (Richardson et al., 1992). 
Transgenic animals containing a number of the casein genes have been generated, 
though transgenes controlled by the casein 5' flanking regions have been expressed at 
relatively low levels as compared to endogenous casein expression. The bovine aSl­
casein, rabbit f)-casein and rat f)-casein 5' flanking regions all have been used to drive 
the expression of transgenes in mice (Lee et al., 1988; Buehler et al., 1990; Meade et 
aI., 1990). Transgenic animals containing these casein constructs showed expression 
levels that were at most 1-10% of endogenous gene expression. From these data it 
was hypothesized that the casein gene cluster (Gupta et aI., 1982; Threadgill & 
Womack, 1990) is regulated by a major control element in addition to the basal 
promoter elements found in the 5' flanking region of each of the casein genes (Lee et 
al., 1989). However, recently it was shown that a caprine f)-casein gene construct 
could be expressed at high levels in the milk of transgenic mice (Persuy et aI., 1992). 
This gene construct was made up of 3·0 kb of 5' flanking, the entire genomic coding 
region, and 6·0 kb of 3' flanking region from the caprine f)-casein gene. Milk from 
animals expressing this transgene contained caprine f)-casein at concentrations up to 
21 mg mL-1 which is twice the level in normal caprine milk. These results indicate 
that the necessary cis-acting elements needed for maximal transgene expression may 
be present in the caprine f)-casein gene construct. 
Due to the discrepancies in the literature with respect to the ability of the casein 
5' flanking regions to drive expression of genes in transgenic animals, we chose to 
test the ability of the bovine a-lactalbumin 5' flanking region to drive the 
production of bovine f)-casein in the milk of transgenic mice and examine the 
characteristics of the mouse milk containing bovine f)-casein. 
MATERIALS AND METHODS 
Isolation of the a-lactalbumin!f)-casein gene construct for microinjection 
An a-lactalbumin/f)-casein gene construct (pA-lac/f)-casein) was developed in our 
laboratory that contained 2·0 kb of bovine a-lactalbumin 5' flanking region, the 
entire 8·5 kb coding region of bovine fJ-casein and 150 bp of I)-casein 3' flanking 
region (Fig. I). This hybrid construct was restriction digested out of the plasmid 
clone (pA-lac 5'/Ii-casein) using the restriction enzyme HhaI. This digestion was 
run on a 1·0% agarose gel and the band containing the 10·7 kb iX-Iactalbumin/{i­
casein construct was purified from the gel using the Qiaex gel extraction kit 
(Qiagen. Chatsworth. CA). The resulting DNA was diluted in TE (IOmM Tris­
HCI. pH = 7-4, I mM EDTA, pH = 8·0) for microinjection. 
Production of transgenic mice 
Mature C57B6 x DBA2J FI (B6D2) female mice were superovulated using 
PMSG and hCG and mated with ICR or B6D2 males to yield fertilized embryos 
for pronuclear microinjection. The embryos were microinjected with the DNA 
construct and 40 normal-appearing two-cell embryos were then transferred to 
each pseudopregnant recipient (University of Wisconsin-Madison Biotechnology 
Center, Transgenic Mouse Facility). The resulting founder transgenic mice were 
then continually backcrossed into the ICR outbred strain of mice. The transgenic 
mice were maintained as heterozyogotes for the transgene throughout the analy­
Sts. 
Identification of transgenic mice 
DNA was extracted from a portion of the mouse tail using the method descri­
bed by Hogan el al. (1986). Polymerase chain reaction (PCR) was performed 
using 10 III lOx PCR reaction buffer (500 mM KCI, 100 mM Tris-HCl 
(pH=8·8). l5mM MgCI2• 1% Triton X-IOO), 200ttM each dNTP. I·OttM each 
primer (Primer I: 5' CTCTTCCTGGATGTAAGGCTT 3'; Primer 2: 5' 
CAAAGTAGAGGACAAGAAGT 3': these primers amplify the junction 
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Fig. I. Map of the iX-LacS' /{i-casein gene construct. The construct contains 2·0 kb of 
bovine iX-lactalbumin S' flanking region (Bleck & BremeL 1993) and 8·5 kb bovine {i-casein 
genomic clone (Bonsing el al.• 1988). The two clones were joined at position +92 bp from 
the ·iX-lactalbumin transcription start point and position -91 bp from the f3-casein tran­
scription start point (tsp). The iX-lactalbumin portion of the construct contains the 5' 
regulatory elements of the iX-lactalbumin gene and the putative 'milk box' (Vilotte Cl al.. 
1987) of the gene sequence. The {i-casein portion of the construct includes the Il-casein 
CAAT box. TATA box, transcription start point. nine exons, polyadenylation signal and 
150bp ofT flanking region. 
between the IX-lactalbumin 5' flanking region and the f3-casein gene), 1 unit Tag 
DNA polymerase and 1 Ilg genomic DNA. Volume was adjusted to 100 ilL with 
double distilled sterile water and reaction was overlaid with light mineral oil. 
Samples were subjected to 30 cycles (94°C 2min, 50°C 1·5min, 72 °C 1·5min). 
Products were run on a 1% agarose gel and stained with ethidium bromide. 
Transgenic mice were characterized by the presence of a PCR band corre­
sponding to the junction between the IX-lactalbumin 5' flanking region and 13­
casein gene. 
Mouse milking 
Mice were separated from their litters for 4h and then anesthetized (0·01 mLg- 1 
body weight intraperitoneal injection of 36% propylene glycol, 10·5% ethyl 
alcohol, 41·5% sterile water, and 12% sodium pentobarbital, 50mgmL-I). After 
being anesthetized the mice were injected intramuscularly with 0·3 international 
units of oxytocin and milked using a small vacuum milking machine. 
Gel electrophoresis and western blotting 
The mouse milk was examined on a 14% SDS-PAGE reducing gel (Laemmli, 
1970) or on a 12·5% Urea-PAGE gel (Swainsgood, 1975). Gels were either 
stained with Coomassie Brilliant Blue R-250 or transferred onto Immobilon-P 
membranes (Millipore, Bedford, MA) for western blotting. Immunoblotting was 
carried out using a rabbit anti-bovine f3-casein antibody (Dr Bruce Larson, 
Urbana, IL) and methods of Jimenez-Flores et al. (1989). 
Histological analysis of mouse mammary glands 
Mammary glands were removed from lactating mice and placed in 10% buffered 
formalin. The glands were then paraffin embedded, sectioned, affixed to micro­
scope slides and stained with hematoxylin and eosin. 
RESULTS 
Generation of transgenic mice 
Four founder transgenic mice containing the bovine lX-lactalbumin/f3-casein gene 
construct were produced. This gene construct contained approximately 2·0 kb of 
bovine IX-lactalbumin 5' flanking region (-1983 bp to +92 pb from the IX-lactal­
bumin transcription start point) attached to a bovine f3-casein genomic clone at 
position -91 bp from the f3-casein transcription start point (Fig. 1). The IX-Lac5'/ 
f3-casein construct therefore contained the proximal promoter elements of 13­
casein and the 5' regulatory elements of IX-lactalbumin. This 91 bp of f3-casein 5' 
flanking region has been shown to be transcriptionally inactive in the mammary 
epithelial eelliine CID-9 (Schmidhauser et al., 1992). Gene constructs containing 
the 91 bp attached to the gene encoding chloramphenicol acetyltransferase (CAT) 
were unable to drive CAT expression in these cells. 
One female founder mouse died before a transgenic line could be established, 
however milk samples were obtained from this mouse for analysis. Transgenic 
lines have been produced from each of the three remaining founder mice and the 
transgenes exhibit normal Mendelian inheritance (~50% of offspring from a 
heterozygous transgenic mouse were transgenic). 
Production of bovine f3-casein in the milk of transgenic mice 
Milk from transgenic mice was analysed using SDS-PAGE and western blotting 
of Urea-PAGE gels. One line of transgenic mice (UWo:/f341) containing the 0:­
LacS'/f3-casein gene construct produced bovine f3-casein up to a concentration of 
approximately to mg mL-1 in their milk (Fig. 2) and two other transgenic lines 
secreted detectable levels of bovine f3-casein in their milk. The concentration of 
bovine f3-casein in all three lines ranged from approximately 1mg mL-I to 
IOmgmL -I in the high producing UWo:/f341 line (Table I). Concentrations of 
protein were estimated using Coomassie Blue stained gels and the Collage8 
image analysis software (FOTODYNE, New Berlin, WI). This is a crude estimate 
of bovine f3-casein concentration. A more precise measurement could not be 
made due to the difficulty in getting a consistent milk sample from these animals 
and also because of the large number of bovine f3-casein proteolytic and phos­
phorylation variants observed. A western blot of the transgenic mouse milk 
indicated a number of protein bands that reacted with the bovine f3-casein anti­
body (Fig. 3). Since bovine f3-casein is a known substrate of plasmin, it is possible 
that the smaller peptides are proteolytic products of the bovine f3-casein. Also, 
bovine f3-casein is known to have a number of phosphorylation variants that may 
show mobility differences in the urea-gel system. 
1 2 3 4 5 6 7 8 
Fig. 2. Coomassie Blue stained SDS-PAGE gel of bovine fJ-casein containing transgenic 
mouse milk. Lane I: control cow milk. Lanes 2 and 3: line UWIJ(-/14l mouse milk (two 
dilutions). Lanes 4. 5 and 6: control mouse milk (samples from three different control 
mice). Lanes 7 and 8: line UWIJ(//141 mouse milk (two dilutions). Arrows indicate location 
of bovine {f-cascin. 
TABLE 1
 
Levels of Bovine /3-Casein Expression in Mouse Milk and Observed Day of Premature
 
Mammary Involution
 
Transgenic line no. Bovine /3-casein expression in Lactation length 
transgenic mouse milk (mg/mL) (days) 
UWex//334 1-3 12-20 
UWex//341 8-12 1-3 
UWex//359 Not detected 20 
UWex//373 3-5 10--15 
Characteristics of the transgenic mouse milk 
The mouse milk containing bovine p-casein exhibited altered physical properties. 
The milk was much more viscous and more difficult to remove from the gland 
compared to control mouse milk. This difficulty in removing milk from the gland 
and the small quantities of milk that could be obtained made it difficult to 
produce consistent milk samples. For this reason, no accurate measurements of 
fat, protein and water were possible for milk of the mice producing the high levels 
of bovine p-casein. The mice producing low levels of the exogenous protein 
("",1 mgmL -1) produced milk with fat, protein and water contents similar to 
control mice. Mice expressing bovine p-casein also underwent a premature invo­
lution of the mammary gland. Mice from the UWa!P41 line which expressed 
bovine p-casein at concentrations of approximately 10 mg mL-I stopped lactating 
on day 1-3 of lactation. Mice from the UWa!p34 line which secreted bovine p­
casein at concentrations of approximately 1-3 mg mL-I stopped lactating on day 
12-18 of lactation, with some finishing a 20 day lactation. However, pups from 
UWa!p34 mice that lactated for a normal length of time appeared much smaller 
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Fig. 3. Western blot of transgenic and control mouse milk. Samples were run on a 12·5% 
Urea-PAGE gel. Lane I: partially purified bovine /3-casein (Sigma Chemical Co., St Louis, 
MO). Lanes 2, 3 and 4: control mouse milk (samples from three different control mice). 
Lanes 5 and 6: transgenic mouse milk (UWex//341). Arrows indicate the relative size of 
endogeneously produced bovine /3-casein. 
than control pups and some UWexl{334 mice continued to lactate past the typical 
20 days if the pups were unable to obtain dry feed and water on their own at day 
20 of lactation. The founder transgenic mouse, UWexl{373, also showed this same 
early involution on approximately day 12 of lactation (two lactations: approx­
imate average involution day), bovine {3-casein concentration in her milk was 
approximately 3-5 mg mL-I. The premature involution was not observed in the 
UWexl{359 line transgenic mice in which bovine {3-casein could not be detected. 
The line UWexl{334 and line UWexl{341 mice that stopped lactating before the 
normal end of lactation went through a normal second pregnancy, started to 
lactate, but then again underwent the same premature involution. Pups from 
these transgenic mice were foster nursed to maintain the transgenic line. 
Mammary gland morphology of transgenic mice producing bovine {3-casein 
On day I or day 3 after parturition, mammary glands from line UWexl{341 trans­
genic mice and from control mice were removed, sectioned and stained to observe 
morphology. Mammary glands from control mice taken on day I of lactation 
showed normal, slightly distended alveolar structures and leftover milk compo­
nents within the alveoli could be observed [Fig. 4(b)]. The mammary glands from 
a day I lactating UWexl{341 mouse were much different as the alveolar structures 
in these glands were more compact and not as distended as the control alveoli 
[Fig. 4(a)]. Alveoli from the transgenic glands contained milk components that 
appeared to be much denser than the components within the control alveoli. 
Similar differences were observed in the glands on day 3 of lactation as the 
alveolar structures from the day 3 control gland were more distended and fuller 
of milk components than day I control alveoli [Fig. 5(b)]. However, the day 3 
transgenic glands had alveolar structures that were smaller or the same size as 
those observed in the day I transgenic glands [Fig. 5(a)]. Milk components within 
these small alveoli again appeared very dense. Large ducts within the day 3 
transgenic glands became very distended and filled with the dense milk compo­
nents [Figs 5(a) and 6(a)] while the control large ducts were very irregular in 
shape and the milk components showed the same appearance as in the control 
alveoli [Fig. 6(b)]. The UWexl{341 mice were milked before the glands were 
removed and no milk could be obtained, yet the glands appeared to be full of 
milk components after sectioning. In addition, glands obtained from transgenic 
mice on day 3 of lactation were approximately twice the size of control mice day 3 
glands. Parts of the UWexl{341 transgenic glands showed involution of the 
mammary alveoli already on day I of lactation [Fig. 7(a) and (b)]. The dense milk 
components remained visible within baskets formed by myoepithelial cells around 
the alveoli, but very few epithelial cells appeared to be present in this structure 
and just a small amount of epithelial cell staining occurred in this region of the 
gland. 
DISCUSSION 
Transgenic mice containing the ex-LacS'I{3-casein gene construct were capable of 
producing a high concentration of bovine {3-casein in their milk. This construct 
demonstrates the utility of combining genetic control regions of two milk protein 
Fig. 4. Mouse mammary glands removed on day I of lactation. (a) Transgenic mammary 
gland section (UWCl/P41), (b) Control mammary gland section. Arrows indicate the 
alveolar lumen. Bar = 10 Jlm. 
Fig. 5. Mouse mammary glands removed on day 3 of lactation. (a) Transgenic mammary 
gland section (UWIX/P41). (b) Control mammary gland section. Arrows indicate the 
alveolar lumen. Bar = 10 tIm. 
Fig. 6. Large ducts from day 3 mouse mammary glands. (a) Transgenic mammary gland 
section (UWIX/P41). (b) Control mammary gland section. Arrows indicate the ductal 
lumen. Bar = 10 11m. 
Fig. 7. Transgenic mouse (UWIX/P41) mammary gland removed on day I of lactation. 
Transgenic mammary gland sections showing involution of the mammary alveoli on day I 
of lactation. Arrows point to regions of apparent mammary involution. Bar = to pm. 
genes to obtain high-level production of a transgene product. By linking 
mammary-specific enhancer regions of various milk protein genes it may be 
possible to obtain a very high production level of transgene products and yet 
maintain the mammary-specificity of the transgene. Similar experiments have 
been attempted using the rat p-casein promoter and the hormone response 
elements of mouse mammary tumor virus (Greenburg et al., 1991). In those 
experiments, the hormone response elements increased transgene expression, but 
some of the mammary-specificity was lost. Enhancer elements from the milk 
protein genes may be able to maintain the mammary specificity and in addition 
increase expression of the gene construct in transgenic animals. 
These data are the first report of a transgene product altering the physical prop­
erties of milk. This appears to be different from the milchlos phenotype that has been 
observed with the over-expression of whey acidic protein in the mammary gland of 
transgenic mice (Burdon et al., 1991). In that study, the over-expression of whey 
acidic protein led to underdeveloped mammary glands that were not capable of 
synthesizing milk. Gland development in the bovine p-casein-expressing mice 
seemed normal, but the milk itself was altered. The modified milk characteristics 
then appeared to induce the premature involution of the mammary gland, and in 
addition the expression of the transgene increased the viscosity of mouse milk. The 
viscous milk was unable to be removed from the gland either by the pups or through 
the use of vacuum aspiration after an oxytocin injection. These properties of the milk 
and the mammary gland were very similar to results obtained when the a-lactal­
bumin gene was "knocked out" of mice (Stinnakre et al., 1994). The build-up of milk 
components within the mammary gland may be causing the premature involution of 
the gland as it has been shown that the rate of mammary involution increases when 
milk is not removed from the gland (Larson, 1985). These additional milk compo­
nents within the gland increase the alveolar pressure which leads to a stoppage of 
milk synthesis and a break up of the alveolar structure. Since the transgenic mice 
were able to go through a normal second pregnancy and start another lactation it 
appeared that no permanent damage was caused by the expression of bovine p­
casein and the early involution of the gland. This indicated that the observed 
phenomenon was similar to a normal involution of the mouse mammary gland. 
The altered physical properties of milk observed in this study were not reported 
to occur in transgenic mice expressing similar levels of caprine p-casein (Persuy et 
al., 1992). Because the two p-caseins are more than 90% conserved at the amino 
acid level, these two sets of data may indicate that functional differences or 
processing variations of the p-casein molecule exist between the cow and the goat 
and that these differences are associated with the unique behavior of bovine p­
casein in mouse milk. A second hypothesis explaining the difference between the 
bovine and the caprine data centers on the use of the bovine a-lactalbumin 5' 
flanking region to control p-casein expression. Typically, a-lactalbumin serves as 
a modulator of lactose production in the mammary gland. Lactose is the major 
osmotic component in milk and its production is associated with the movement 
of water into the lumen of the mammary gland. A reduction in the amount of a­
lactalbumin produced may cause less lactose to be produced and less water 
movement into the gland, resulting in a more viscous milk. The a-lactalbumin 5' 
flanking region controlling the p-casein gene construct may be sequestering 
necessary transcription factors needed for the production of normal mouse a­
lactabumin and thus causing decreased production of mouse a-lactalbumin and 
lactose. The possibility that a transcription factor may be rate limiting has been 
suggested by a number of authors (Hirst et al., 1990; Wang & Miksicek, 1991; 
Colgan & Manley, 1992). Studies are underway to examine the functional differ­
ences between bovine fJ-casein-containing mouse milk and control mouse milk 
with regards to apparent viscosity, composition and the potential bovine fJ-casein 
variants observed in the mouse milk. 
CONCLUSIONS 
Transgenic mice producing a high level of bovine fJ-casein yielded abnormal milk 
and stopped lactating before the normal onset of involution. These mice may 
serve as a useful model to study the mechanisms of mammary involution as well 
as the functional changes induced by the presence of bovine fJ-casein in mouse 
milk. The bovine a-lactalbumin 5' flanking region proved to be a useful regula­
tory region for driving bovine fJ-casein production in the milk of transgenic mice. 
The a-Lac5'/fJ-casein gene construct can be used to make mutations in the fJ­
casein gene and then to test the effects of these changes on the physical char­
acteristics of modified bovine fJ-casein in the milk of transgenic animals. 
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